CapsoVision, Inc. (CV) Deep Dive Video

Summary

CapsoVision’s wire-free, zero-capex capsule endoscopy platform—now FDA-cleared for at-home remote ingestion—sets up a small-cap “workflow disruption” story with major upside from colon and pancreatic screening optionality.

View CV stock page · Read the CV research report

Loading the video player…